← FDA Drug Approvals (Drugs@FDA)
LO LARIN FE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS LTD · Approved 2016-12-20
Drug application
- FDA Application #
ANDA208661
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LO LARIN FE
- Generic name
- Ethinyl Estradiol
- Active ingredients
- ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- NOVAST LABS LTD
- First approval
- 2016-12-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown